Helen Tomkinson
Impact in
- Modeling and Simulation top 10%
-
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 5
- PARP inhibition in cancer therapy 4
-
- PI3K/AKT/mTOR signaling in cancer 7
- Melanoma and MAPK Pathways 4
- Receptor Mechanisms and Signaling 3
- Co-authors
- Nidal Al‐Huniti (8 shared papers)Eric Masson (6 shared papers)Gabriel Helmlinger (4 shared papers)Lulu Chu (2 shared papers)Kirill Peskov (2 shared papers)Karthick Vishwanathan (7 shared papers)Donald R. Stanski (1 shared paper)Veronika Voronova (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (5 papers)The Journal of Clinical Pharmacology (4 papers)Cancer Research (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
Helen Tomkinson
38 papers receiving 434 citations
Peers
Comparison fields: 5 of 77
- Modeling and Simulation 31
- Oncology 178
- Genetics 62
- Hematology 61
- Pharmacology 37
Countries citing papers authored by Helen Tomkinson
This map shows the geographic impact of Helen Tomkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Tomkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Tomkinson more than expected).
Fields of papers citing papers by Helen Tomkinson
This network shows the impact of papers produced by Helen Tomkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Tomkinson. The network helps show where Helen Tomkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Tomkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2017 | 38 | |
| 3 | 2011 | 27 | |
| 4 | 2018 | 25 | |
| 5 | 2017 | 24 | |
| 6 | 2018 | 16 | |
| 7 | 2017 | 15 | |
| 8 | 2021 | 14 | |
| 9 | 2019 | 14 | |
| 10 | 2022 | 14 | |
| 11 | 2017 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2018 | 13 | |
| 14 | 2017 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2011 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2021 | 8 |
About Helen Tomkinson
Helen Tomkinson is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Hematology, having authored 40 papers that have together received 447 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Melanoma and MAPK Pathways (4 papers), Cancer Genomics and Diagnostics (4 papers), PARP inhibition in cancer therapy (4 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Modeling and Simulation (31 citations), Oncology (178 citations), Genetics (62 citations), Hematology (61 citations) and Pharmacology (37 citations). Helen Tomkinson has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include Nidal Al‐Huniti, Eric Masson, Gabriel Helmlinger, Lulu Chu, Kirill Peskov, Karthick Vishwanathan, Donald R. Stanski, Veronika Voronova, Simon J. Dovedi and Yuri Kosinsky. Their work appears in journals such as British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Cancer Research, Clinical Pharmacology & Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.